Pyrimidine

Pyrimidine

SCHEMBL3397113

O=C(Nc1ccccc1-c1cc2ccccc2[nH]1)c1ccccc1.c1cncnc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.52
STK33 Q9BYT3 4/20 0.51
PARP14 Q460N5 1/20 0.48
P2RY1 P47900 1/20 0.47
IDO1 P14902 1/20 0.46
KDR P35968 1/20 0.44
EGFR P00533 1/20 0.44
PIK3CA P42336 1/20 0.44
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ABCG2 Q9UNQ0 2/20 0.43
ABCB1 P08183 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11724397 0.92 PARP14 (0.55) ITKSTK33PARP14P2RY1KDR
SCHEMBL3737843 0.83 P2RY1 (0.51) ITKSTK33PARP14P2RY1KDR
SCHEMBL23729917 0.82 P2RY1 (0.50) ITKSTK33PARP14P2RY1KDR
SCHEMBL3738262 0.80 TOP1 (0.58) ITKSTK33PARP14P2RY1KDR
SCHEMBL3742777 0.79 TOP1 (0.59) STK33PARP14P2RY1KDRPOLB
SCHEMBL3538594 0.78 P2RY1 (0.51) P2RY1KDRNPC1RAB9ALMNA
SCHEMBL2740084 0.77 MEN1 (0.56) STK33PARP14P2RY1EGFRPIK3CA
SCHEMBL3782068 0.76 KDM4E (0.52) STK33P2RY1KDRHPGDSMN1; SMN2
SCHEMBL3749549 0.76 PTPN1 (0.47) ITKSTK33P2RY1CYP3A4
SCHEMBL11726409 0.76 P2RY1 (0.56) ITKPARP14P2RY1KDRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222381-A1 Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors VANKAYALAPATI HARIPRASAD 2010-09-02 US disclosed
WO-2010098866-A1 CYCLOPENTATHIOPHENE/CYCLOHEXATHIOPHENE DNA METHYLTRANSFERASE INHIBITORS SUPERGEN, INC. (US) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222381-A1 Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors DNMT3B, DNMT1, DNMT3L ITK 4268/4885STK33 2629/4885PARP14 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.